Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors

NCT05668585

Conditions
ATC, CRC, Melanoma, +13 more
Locations
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Completed

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

NCT01397708

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic Los Angeles, California, United States
  • Oncology Specialists Park Ridge, Illinois, United States
  • Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States
  • James Graham Brown Cancer Center Louisville, Kentucky, United States
View Trial Details
Completed

Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)

NCT04700072

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • The Angeles Clinic and Research Institute ( Site 4009) Los Angeles, California, United States
  • UCLA Hematology & Oncology ( Site 4004) Los Angeles, California, United States
  • Providence Saint John's Health Center ( Site 4010) Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 4012) Aurora, Colorado, United States
View all 36 locations
View Trial Details
Completed

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

NCT04208958

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +28 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • The Angeles Clinic and Research Institute - West Los Angeles Office Santa Monica, California, United States
View all 18 locations
View Trial Details
Completed

Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)

NCT04303169

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • The Angeles Clinic and Research Institute ( Site 3009) Los Angeles, California, United States
  • Providence Saint John's Health Center ( Site 3010) Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 3012) Aurora, Colorado, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 3022) Baltimore, Maryland, United States
View all 29 locations
View Trial Details
Completed

A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors

NCT05091346

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, Irvine Health Orange, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • SCRI Florida Cancer Specialists East West Palm Beach, Florida, United States
View all 32 locations
View Trial Details

Related conditions